Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
Comparing intermediate-dose CTX (ID-CTX)and G-CSF with rhTPO or without for peripheral blood stem cell mobilization in patients with multiple myeloma, try to find out whether rhTPO combined to ID-CTX + G-CSF could improve the results of peripheral blood stem cell mobilization.
Epistemonikos ID: 876cfd7c11c6178f5b5e00559fc41ea6a54e0972
First added on: May 12, 2024